Economic Evaluation of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.1715
https://www.valueinhealthjournal.com/article/S1098-3015(18)32037-0/fulltext
Section Title :
Section Order :
934
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32037-0&doi=10.1016/j.jval.2018.04.1715